Perceptive Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Perceptive Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-310,000	Closed	-$18.5M	–	125
2019 Q4	$18.5M	Buy	310,000 +303,578	+4,727%	+$18.7M	0.37%	50
2019 Q3	$379K	Hold	6,422	–	–	0.01%	103
2019 Q2	$414K	Sell	6,422 -6,422	-50%	-$414K	0.01%	99
2019 Q1	$816K	Hold	12,844	–	–	0.02%	86
2018 Q4	$479K	Buy	+12,844	New	+$454K	0.02%	89
2016 Q2	–	Sell	-2,500	Closed	-$217K	–	199
2016 Q1	$217K	Hold	2,500	–	–	0.02%	150
2015 Q4	$295K	Buy	+2,500	New	+$248K	0.02%	109
2014 Q2	–	Sell	-10,590	Closed	-$2.34M	–	141
2014 Q1	$2.34M	Sell	10,590 -1,970	-16%	-$502K	0.25%	61
2013 Q4	$3.24M	Buy	+12,560	New	+$2.87M	0.39%	43

Other funds holding TNDM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Perceptive Advisors's TNDM Position: Q1 2020 in Review

Perceptive Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2020, closing a stake of 310,000 shares — an estimated $18.5M sold.

Perceptive Advisors first reported a position in TNDM in Q4 2013 and held it in 9 quarters. The position peaked at $18.5M in Q4 2019. 279 funds tracked by Wall St. Rank hold TNDM as of Q1 2020.

Perceptive Advisors reported no remaining Tandem Diabetes Care position as of Q1 2020 after selling out during the quarter.
Perceptive Advisors sold 310,000 Tandem Diabetes Care shares in Q1 2020, an estimated $18.5M.
Perceptive Advisors first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 9 quarters.
Perceptive Advisors's Tandem Diabetes Care position peaked at $18.5M in Q4 2019.
279 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2020.

Based on Perceptive Advisors's 13F filing for Q1 2020, filed 15 May 2020.